Literature DB >> 12225001

Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18 cases.

Oliver Dereure, Didier Bessis, Bernard Guillot, Jean-Jacques Guilhou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225001     DOI: 10.1001/archderm.138.9.1255

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

3.  Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature.

Authors:  Meital Oren-Shabtai; Noa Kremer; Moshe Lapidoth; Eran Sharon; Lihi Atzmony; Adi Nosrati; Emmilia Hodak; Daniel Mimouni; Assi Levi
Journal:  Drugs Aging       Date:  2020-11-24       Impact factor: 3.923

4.  Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid-A Single Center Retrospective Analysis.

Authors:  Agoritsa Gravani; Georgios Gaitanis; Panagiota Spyridonos; Ioannis Alexis; Stelios Tigas; Ioannis D Bassukas
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

5.  Role of methotrexate in the treatment of bullous pemphigoid in the elderly.

Authors:  Timothy Patton; Neil Korman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Alleviation effects of natural volatile organic compounds from Pinus densiflora and Chamaecyparis obtusa on systemic and pulmonary inflammation.

Authors:  Changhwan Ahn; Jae-Hwan Lee; Jae-Woo Kim; Mi-Jin Park; Sung-Suk Lee; Eui-Bae Jeung
Journal:  Biomed Rep       Date:  2018-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.